• CEO of Ambu A/S.
• Member of the Board of Novo Holdings A/S.
• Member of the Board of Hempel A/S.

• CEO of Swedish Medtech company, Atos Medical AB, owned by PAI partners, 2019-2022.
• President and CEO of the Danish public biotech company, Zealand Pharma A/S, 2015-2019.
• CEO of Dako A/S, 2013-2014.
• Leadership roles at Novo Nordisk A/S, including being Corporate Vice President of Global Marketing, Market Access & Commercial Excellence, 2002-2013.
• Management Consultant in McKinsey & Company, 2000-2002.

• Considered not independent under the Danish Corporate Governance Recommendations.
• Member of the Board of Directors since November 2025. 
• Member of the Research & Development Committee since November 2025.
• Member of the Remuneration Committee since November 2025.

• Global corporate leadership.
• Healthcare & pharma industry.
• Human capital management.
• Technology, data & digital.
• Business development, M&A and external innovation sourcing.

• 2000: MSc in International Marketing and Management, Copenhagen Business School, Denmark.
• 1998: MBA, Solvay Business School, ULB, Belgium.

Danish. Born in 1973. Female.